K Pharma,Inc.
Develops iPS cell-based drugs and regenerative medicine for central nervous system disorders.
4896 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 港区六本木七丁目７番７号
- Website:
- https://en.kpharma.co.jp/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
K Pharma, Inc. is a biotechnology company established as a spin-off from the Keio University School of Medicine to commercialize research in induced pluripotent stem (iPS) cell technology. The company engages in the research, development, manufacturing, and sale of pharmaceuticals and regenerative medicine products. Its business is centered on two key areas: iPS drug discovery, which utilizes disease-specific iPS cells to develop new therapies, and regenerative medicine. The company's primary therapeutic focus is on the central nervous system (CNS), developing applications for nerve regeneration to treat conditions such as spinal cord injuries and cerebral infarctions.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for K Pharma,Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-14 02:30 |
Interim Report
半期報告書－第9期(2025/01/01－2025/12/31)
|
Japanese | 179.3 KB | |
| 2025-08-14 02:30 |
Regulatory News Service
確認書
|
Japanese | 8.8 KB | |
| 2025-03-28 02:01 |
Regulatory News Service
臨時報告書
|
Japanese | 24.2 KB | |
| 2025-03-28 02:00 |
Regulatory News Service
内部統制報告書－第8期(2024/01/01－2024/12/31)
|
Japanese | 22.4 KB | |
| 2025-03-28 02:00 |
Annual Report
有価証券報告書－第8期(2024/01/01－2024/12/31)
|
Japanese | 1.5 MB | |
| 2025-03-28 02:00 |
Regulatory News Service
確認書
|
Japanese | 8.8 KB | |
| 2024-08-14 08:00 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2024-08-14 08:00 |
Interim Report
半期報告書－第8期(2024/01/01－2024/12/31)
|
Japanese | 182.0 KB | |
| 2024-05-14 02:00 |
Quarterly Report
四半期報告書－第8期第1四半期(2024/01/01－2024/03/31)
|
Japanese | 136.5 KB | |
| 2024-05-14 02:00 |
Regulatory News Service
確認書
|
Japanese | 8.8 KB | |
| 2024-03-29 02:30 |
Regulatory News Service
臨時報告書
|
Japanese | 22.6 KB | |
| 2024-03-28 07:01 |
Regulatory News Service
確認書
|
Japanese | 8.8 KB | |
| 2024-03-28 07:00 |
Regulatory News Service
内部統制報告書－第7期(2023/01/01－2023/12/31)
|
Japanese | 22.4 KB | |
| 2024-03-28 07:00 |
Annual Report
有価証券報告書－第7期(2023/01/01－2023/12/31)
|
Japanese | 1.5 MB | |
| 2023-11-13 07:01 |
Regulatory News Service
確認書
|
Japanese | 8.8 KB |
Automate Your Workflow. Get a real-time feed of all K Pharma,Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for K Pharma,Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
